KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) EBT (2016 - 2025)

LifeMD's EBT history spans 14 years, with the latest figure at -$6.0 million for Q4 2025.

  • For Q4 2025, EBT rose 8.27% year-over-year to -$6.0 million; the TTM value through Dec 2025 reached -$9.0 million, up 63.42%, while the annual FY2025 figure was -$10.2 million, 54.88% up from the prior year.
  • EBT reached -$6.0 million in Q4 2025 per LFMD's latest filing, down from -$3.4 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $1.5 million in Q1 2025 to a low of -$18.0 million in Q4 2021.
  • Average EBT over 5 years is -$7.8 million, with a median of -$6.6 million recorded in 2024.
  • Peak YoY movement for EBT: tumbled 393.98% in 2021, then skyrocketed 123.01% in 2025.
  • A 5-year view of EBT shows it stood at -$18.0 million in 2021, then soared by 37.69% to -$11.2 million in 2022, then skyrocketed by 75.08% to -$2.8 million in 2023, then crashed by 135.36% to -$6.6 million in 2024, then grew by 8.27% to -$6.0 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's EBT are -$6.0 million (Q4 2025), -$3.4 million (Q3 2025), and -$1.1 million (Q2 2025).